Skip to content

Vivani Medical VANI Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration

Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration at other companies

Security National Financial Corporation logo
Security National Financial CorporationSNFCA
$568.3K-82.1%
IBT
IbottaIBTA
$74.9M
ROC
Rank One Computing ROC
$2.04K
Popular logo
PopularBPOP
$627.73M-5.2%
ESAB logo
ESABESAB
$2.2M-56.9%
VAN
Vivani MedicalVANI
$47.35M0.0%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's deferred tax assets operating loss carryforwards not subject to expiration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's deferred tax assets operating loss carryforwards not subject to expiration?
Vivani Medical (VANI) reported deferred tax assets operating loss carryforwards not subject to expiration of $206.73M in Q4 2025.
What is the long-term trend for Vivani Medical's deferred tax assets operating loss carryforwards not subject to expiration?
Over 2 years (2023 to 2025), Vivani Medical's deferred tax assets operating loss carryforwards not subject to expiration has grown at a 23.1% compound annual growth rate (CAGR), from $136.33M to $206.73M.